Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.

● According to Refinitiv, the company's ESG score for its industry is good.


Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● Its low valuation, with P/E ratio at 2.72 and 8.33 for the ongoing fiscal year and 2023 respectively, makes the stock pretty attractive with regard to earnings multiples.

● With regards to fundamentals, the enterprise value to sales ratio is at 0.64 for the current period. Therefore, the company is undervalued.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● For several months, analysts have been revising their EPS estimates roughly upwards.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● Consensus analysts have strongly revised their opinion of the company over the past 12 months.


Weaknesses

● As estimated by analysts, this group is among those businesses with the lowest growth prospects.

● The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.

● Over the past four months, analysts' average price target has been revised downwards significantly.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.